The FDA has cleared the new Covid booster shots that target the Omicron subvariants that are prominent right now.  The shots are likely to be offered very soon but complicating the efforts will be the vaccine fatigue that has set in and the fact that these shots have been cleared without results from clinical trials.  Vaccine experts say it is not needed since it’s just an update to a proven shot and is similar to the process for flu shots.  Liz Whyte, reporter at the WSJ, joins us for what to know about the retooled boosters.

 

Next, get ready for the magic mushroom pill!  As the medical benefits of psychedelic drugs has moved into solid science and more mainstream startups are racing ahead to bring products to market.  Psilocybin and other psychedelics have shown promise in treating conditions like depression and PTSD and is especially effective when paired with therapy.  As a result, we are seeing an industry pop up that could see a global market for psychedelic pharmaceuticals reach $6.9 billion by 2027.  Kristen V Brown, health editor and reporter at Bloomberg News, joins us for more.

See omnystudio.com/listener for privacy information.